Donald Trump needed just 20 minutes to knock $24.6 billion in value from the nine biggest Big Pharma companies. That was the statistic bandied about recently when the president-elect, at a much-anticipated press conference, declared that pharmaceuticals are “getting away with murder.” That’s ironic, because investors targeting the sure-fire dividends of
- Motley Fool•3 days ago
Glaxo's product churn negatively impacted its valuation in 2016 -- but better days appear to be close at hand.
- Motley Fool•4 days ago
We're starting to see the effects of restructuring. It's working.
GSK.L : Summary for GLAXOSMITHKLINE PLC ORD 25P - Yahoo Finance
GlaxoSmithKline plc (GSK.L)
LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
|Bid||1,554.50 x 175400|
|Ask||1,555.00 x 417900|
|Day's Range||1,554.00 - 1,581.50|
|52 Week Range||1,314.26 - 1,745.56|
|PE Ratio (TTM)||254.84|
|Dividend & Yield||0.93 (4.87%)|
|1y Target Est||N/A|